0000899243-22-030800.txt : 20220912
0000899243-22-030800.hdr.sgml : 20220912
20220912163020
ACCESSION NUMBER: 0000899243-22-030800
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220908
FILED AS OF DATE: 20220912
DATE AS OF CHANGE: 20220912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARKISON BRIAN A
CENTRAL INDEX KEY: 0001283061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 221238891
MAIL ADDRESS:
STREET 1: 501 FIFTH STREET
CITY: BRISTOL
STATE: TN
ZIP: 37620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-08
0
0001521036
Lantheus Holdings, Inc.
LNTH
0001283061
MARKISON BRIAN A
C/O LANTHEUS HOLDINGS, INC.
331 TREBLE COVE ROAD
NORTH BILLERICA
MA
01862
1
0
0
0
Common Stock
2022-09-08
4
M
0
3263
21.13
A
53231
D
Common Stock
2022-09-08
4
M
0
9464
19.11
A
62695
D
Common Stock
2022-09-08
4
M
0
11725
17.06
A
74420
D
Common Stock
2022-09-08
4
S
0
4172
83.045
D
70248
D
Common Stock
2022-09-08
4
S
0
23852
84.1038
D
46396
D
Common Stock
2022-09-08
4
S
0
13788
84.8408
D
32608
D
Stock Option (right to buy)
21.13
2022-09-08
4
M
0
3263
0.00
D
2014-04-30
2023-04-30
Common Stock
3263
0
D
Stock Option (right to buy)
19.11
2022-09-08
4
M
0
9464
0.00
D
2023-05-06
Common Stock
9646
0
D
Stock Option (right to buy)
17.06
2022-09-08
4
M
0
11725
0.00
D
2024-01-23
Common Stock
11725
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.455 to $83.44, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.48 to $84.475, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.48 to $85.33, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
The stock options under this grant vested in equal monthly installments over the twelve months beginning on May 6, 2013.
The stock options under this grant vested in equal monthly installments over the twelve months beginning on January 23, 2014.
/s/ Eric M. Green, attorney-in-fact
2022-09-12